Grantham, Mayo, Van Otterloo & Co (GMO)
HLN icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Haleon HLN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio HLN Stock Details HLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9M Sell
1,486,022
-411,672
-22% -$3.83M 0.03% 225
2026
Q1 		$19M Buy
1,897,694
+299,404
+19% +$3.11M 0.05% 191
2025
Q4 		$16.2M Buy
1,598,290
+709,451
+80% +$6.74M 0.04% 196
2025
Q3 		$7.97M Buy
888,839
+103,601
+13% +$998K 0.02% 253
2025
Q2 		$8.14M Buy
785,238
+331,056
+73% +$3.49M 0.02% 244
2025
Q1 		$4.67M Buy
454,182
+61,773
+16% +$608K 0.01% 304
2024
Q4 		$3.74M Buy
392,409
+310,194
+377% +$3.04M 0.01% 327
2024
Q3 		$870K Buy
82,215
+43,707
+114% +$423K ﹤0.01% 460
2024
Q2 		$318K Buy
38,508
+9,974
+35% +$83.4K ﹤0.01% 479
2024
Q1 		$242K Buy
28,534
+25,619
+879% +$214K ﹤0.01% 485
2023
Q4 		$24K Buy
+2,915
New +$24K ﹤0.01% 485
2023
Q2 		– Sell
-893,400
Closed -$7.27M – 708
2023
Q1 		$7.27M Sell
893,400
-149,300
-14% -$1.19M 0.04% 283
2022
Q4 		$8.34M Buy
1,042,700
+493,200
+90% +$3.36M 0.04% 262
2022
Q3 		$3.35M Buy
+549,500
New +$3.56M 0.02% 377

Other funds holding HLN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s HLN Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Haleon (HLN) stake by 22% in Q2 2026, selling an estimated $3.83M and leaving 1,486,022 shares worth $13.9M. The position accounts for 0.03% of the portfolio, ranked #225.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HLN in Q3 2022 and has held it in 14 quarters since. The position peaked at $19M in Q1 2026. 641 funds tracked by Wall St. Rank hold HLN as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 1,486,022 shares of Haleon worth $13.9M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 411,672 Haleon shares in Q2 2026, an estimated $3.83M.
  • Haleon made up 0.03% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #225 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Haleon in Q3 2022 and has held it in 14 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Haleon position peaked at $19M in Q1 2026.
  • 641 funds tracked by Wall St. Rank held Haleon as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.